Article Text

Download PDFPDF

4CPS-237 Feasibility of continuous administration of antimicrobials in hospital: nothing is ever as it seems?
  1. V Grootaert1,
  2. K Bigler1,
  3. A Bervoet2,
  4. J Van Praet3,
  5. E Nulens4
  1. 1Az Sint-Jan Brugge-Oostende Av, Pharmacy, Bruges, Belgium
  2. 2Az Sint-Jan Brugge-Oostende Av, Intravenous Vascular Acces Team, Bruges, Belgium
  3. 3Az Sint-Jan Brugge-Oostende Av, Department of Nephrology and Infectious Diseases, Bruges, Belgium
  4. 4Az Sint-Jan Brugge – Oostende Av, Department of Laboratory Medicine, Bruges, Belgium


Background and importance Continuous infusion (CI) of antimicrobials is increasingly applied because of the pharmacokinetic and practical advantages, including the rapid achievement of stable target serum concentrations, ease of sampling as levels are determined during steady state and simple interpretation of therapeutic drug monitoring.

Aim and objectives To assess medication administration practices related to CI of antimicrobials.

Material and methods During a 10 day prospective observational survey in March 2019, we enrolled all consecutive hospitalised non-ICU patients who received at least one antimicrobial suitable for CI. Amoxicillin, aztreonam, benzylpenicillin, ceftazidime, flucloxacillin, meropenem, piperacillin/tazobactam, temocillin and vancomycin were included as antimicrobials. Catheter type, number of lumens, administration mode, loading and maintenance dose, and pump settings were assessed by comparing the electronic prescription and patient file with the observations. Drug incompatibilities (DI) were analysed using the compatibility information provided in Trissel’s two clinical pharmaceutics database and categorised as compatible, incompatible, uncertain or none. DI were defined as incompatibility or uncertainty about the compatibility between at least two simultaneously Y site administered drugs.

Results 107 observations in 86 patients were performed and 113 antimicrobial prescriptions were analysed. Peripheral lines were most commonly used (53%), followed by central venous catheters (35%) and peripherally inserted central catheters (10%). Single, double, triple and quadruple lumen catheters accounted for 56%, 23%, 17% and 4%, respectively. CI therapy was prescribed, according to hospital guidelines, in 96% of patients, 93% of whom received a loading dose. In 96% of cases a correct maintenance dose was administered. Only 63% of the infusion bags/syringes were labelled appropriately. In 7% of the observations, the pump settings did not match the prescribed dose, causing both over and under dosing in three patients (defined as >105% and <95% of the prescribed daily dose, respectively). We observed DI in 28% (30/107) of cases, mostly with single lumen catheters (63%), and in haematological patients (37%). Moreover, change from CI to intermittent infusion was the only solution to overcome DI in 73% of these cases.

Conclusion and relevance We found that administration issues were common in CI of antimicrobials. In response, we started educational sessions, the hospital policy was slightly adapted, including allowing intermittent infusion in the case of DI, and we created a prescribing alert for the assistance of a clinical pharmacist for DI review.

Conflict of interest No conflict of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.